Glucotrack, Inc. (GCTK) › Cash & EquivalentsGlucotrack, Inc. (GCTK) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $526.3K2009: $62.0K2010: $1.49M2011: $1.90M2012: $543.4K2013: $2.39M2014: $5.83M2015: $608.7K2016: $148.8K2017: $53.8K2018: $97.1K2019: $419.0K2020: $9.82M2021: $6.06M2022: $2.31M2023: $4.49M2024: $5.62M2025: $7.38M$7.38M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$7.38M+31.4%2024$5.62M+25.0%2023$4.49M+94.3%2022$2.31M-61.9%2021$6.06M-38.3%2020$9.82M+2244.4%2019$419.0K+331.6%2018$97.1K+80.5%2017$53.8K-63.9%2016$148.8K-75.5%2015$608.7K-89.6%2014$5.83M+144.2%2013$2.39M+339.1%2012$543.4K-71.3%2011$1.90M+26.9%2010$1.49M+2308.8%2009$62.0K-88.2%2008$526.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share